PUBLISHER: 360iResearch | PRODUCT CODE: 1611989
PUBLISHER: 360iResearch | PRODUCT CODE: 1611989
Acute Kidney Injury Treatment Market (AKI) by Product (Dialysis, Drug Therapy), Injury Type (Intrinsic-Renal Acute Kidney Injury, Post-Renal Acute Kidney Injury, Pre-Renal Acute Kidney Injury), End-User - Global Forecast 2025-2030
The Acute Kidney Injury Treatment Market was valued at USD 1.87 billion in 2023, expected to reach USD 2.02 billion in 2024, and is projected to grow at a CAGR of 7.81%, to USD 3.17 billion by 2030.
Acute Kidney Injury (AKI) treatment is an evolving segment in the healthcare market, rooted in the need for effective therapeutic interventions to manage sudden kidney function loss. The necessity of AKI treatment stems from its high morbidity and mortality rates, making early and accurate interventions crucial. Current applications focus on enhancing renal recovery, managing fluid balance, electrolyte disturbances, and minimizing further renal damage. These treatments serve hospitals, dialysis centers, and intensive care units, reflecting a high end-use scope across critical care settings. Key growth factors influencing this market include the rising prevalence of chronic diseases like diabetes and hypertension, an aging population, and advancements in diagnostic techniques and monitoring technologies. Potential opportunities lie in the development of innovative therapies such as stem-cell treatment, next-gen dialysis products, and biomarkers for early AKI detection, which can significantly enhance patient outcomes. Companies can leverage collaborative research with academic institutions to fast-track innovation and widen therapeutic portfolios. However, the market faces limitations including high treatment costs, the shortage of skilled nephrologists, and the complex nature of multi-organ failure in critical patients. Moreover, regulatory challenges and the need for extensive clinical validation can delay product launches. Despite these challenges, innovation areas such as AI-driven predictive analytics, personalized medicine approaches, and novel kidney support devices can pave the way for substantial market growth. The AKI treatment market is characterized by a dynamic nature, with a strong emphasis on technological developments and therapeutic advancements. Insights into market dynamics can guide businesses to make informed investment decisions, prioritize R&D efforts, and collaborate strategically. Comprehensive market analysis reveals that addressing unmet medical needs and improving existing treatment efficacy are pivotal pathways toward sustainable business expansion in the AKI treatment landscape.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 1.87 billion |
| Estimated Year [2024] | USD 2.02 billion |
| Forecast Year [2030] | USD 3.17 billion |
| CAGR (%) | 7.81% |
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Acute Kidney Injury Treatment Market
The Acute Kidney Injury Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- Rising number of kidney failures and kidney-related diseases
- Growing number of drug approvals for the treatment of kidney disorders
- Government initiatives to raise awareness about kidney health
- Market Restraints
- High cost of availing treatment and lack of reimbursements
- Market Opportunities
- Advancements to enhance kidney treatment options and improve disease detection
- New hospitals providing kidney treatment and improvements in outpatient care
- Market Challenges
- Stringent regulations concerning certain kidney injury treatment options
Porter's Five Forces: A Strategic Tool for Navigating the Acute Kidney Injury Treatment Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Acute Kidney Injury Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Acute Kidney Injury Treatment Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Acute Kidney Injury Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Acute Kidney Injury Treatment Market
A detailed market share analysis in the Acute Kidney Injury Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Acute Kidney Injury Treatment Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Acute Kidney Injury Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the Acute Kidney Injury Treatment Market
A strategic analysis of the Acute Kidney Injury Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the Acute Kidney Injury Treatment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alloksys Life Sciences B.V., Amgen Inc., Angion Biomedica Corp., Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Baxter International, Inc., Bayer AG, bioMerieux SA, Dr. Reddys Laboratories Ltd., Fresenius Medical Care AG & Co. KGaA, GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Otsuka Pharmaceutical Co., Ltd., Pfizer Inc., Reata Pharmaceuticals Inc. by Biogen Inc., Rockwell Medical, Inc., Silver Creek Pharmaceuticals, Inc., Stealth BioTherapeutics, Inc., and Teva Pharmaceutical Industries Ltd..
Market Segmentation & Coverage
This research report categorizes the Acute Kidney Injury Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Product, market is studied across Dialysis and Drug Therapy. The Dialysis is further studied across Continuous Renal Replacement Therapy (CRRT), Intermittent Hemodialysis, and Sustained Low-Efficiency Dialysis (SLED). The Drug Therapy is further studied across Antibiotics, Diuretics, and Immunosuppressive Agents.
- Based on Injury Type, market is studied across Intrinsic-Renal Acute Kidney Injury, Post-Renal Acute Kidney Injury, and Pre-Renal Acute Kidney Injury.
- Based on End-User, market is studied across Ambulatory Surgical Centers and Hospitals.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising number of kidney failures and kidney-related diseases
- 5.1.1.2. Growing number of drug approvals for the treatment of kidney disorders
- 5.1.1.3. Government initiatives to raise awareness about kidney health
- 5.1.2. Restraints
- 5.1.2.1. High cost of availing treatment and lack of reimbursements
- 5.1.3. Opportunities
- 5.1.3.1. Advancements to enhance kidney treatment options and improve disease detection
- 5.1.3.2. New hospitals providing kidney treatment and improvements in outpatient care
- 5.1.4. Challenges
- 5.1.4.1. Stringent regulations concerning certain kidney injury treatment options
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.2.1. Product: Rising number of research initiatives to improve dialysis treatment
- 5.2.2. Injury type: Awareness about underlying causes of kidney injury leading to the creation of treatments for Intrinsic-Renal Acute Kidney Injury
- 5.2.3. End-user: Improvements in outpatient care leading to rising prevalence of ambulatory surgical centers (ASCs)
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. Acute Kidney Injury Treatment Market, by Product
- 6.1. Introduction
- 6.2. Dialysis
- 6.2.1. Continuous Renal Replacement Therapy (CRRT)
- 6.2.2. Intermittent Hemodialysis
- 6.2.3. Sustained Low-Efficiency Dialysis (SLED)
- 6.3. Drug Therapy
- 6.3.1. Antibiotics
- 6.3.2. Diuretics
- 6.3.3. Immunosuppressive Agents
7. Acute Kidney Injury Treatment Market, by Injury Type
- 7.1. Introduction
- 7.2. Intrinsic-Renal Acute Kidney Injury
- 7.3. Post-Renal Acute Kidney Injury
- 7.4. Pre-Renal Acute Kidney Injury
8. Acute Kidney Injury Treatment Market, by End-User
- 8.1. Introduction
- 8.2. Ambulatory Surgical Centers
- 8.3. Hospitals
9. Americas Acute Kidney Injury Treatment Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
10. Asia-Pacific Acute Kidney Injury Treatment Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
11. Europe, Middle East & Africa Acute Kidney Injury Treatment Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
12. Competitive Landscape
- 12.1. Market Share Analysis, 2023
- 12.2. FPNV Positioning Matrix, 2023
- 12.3. Competitive Scenario Analysis
- 12.3.1. Novartis to Buy Chinook for Up to USD 3.5 Billion, Expanding Kidney Disease Pipeline
- 12.3.2. CalciMedica Announces Closing of Merger with Graybug Vision and Concurrent Private Placement
- 12.3.3. SeaStar Medical Receives FDA Approval to Begin Study with Selective Cytopheretic Device to Reduce Hyperinflammation in Adults with Acute Kidney Injury
- 12.4. Strategy Analysis & Recommendation
Companies Mentioned
- 1. Abbott Laboratories
- 2. Alloksys Life Sciences B.V.
- 3. Amgen Inc.
- 4. Angion Biomedica Corp.
- 5. Asahi Kasei Medical Co., Ltd.
- 6. B. Braun Melsungen AG
- 7. Baxter International, Inc.
- 8. Bayer AG
- 9. bioMerieux SA
- 10. Dr. Reddys Laboratories Ltd.
- 11. Fresenius Medical Care AG & Co. KGaA
- 12. GlaxoSmithKline PLC
- 13. Johnson & Johnson Services, Inc.
- 14. Merck & Co., Inc.
- 15. Novartis AG
- 16. Otsuka Pharmaceutical Co., Ltd.
- 17. Pfizer Inc.
- 18. Reata Pharmaceuticals Inc. by Biogen Inc.
- 19. Rockwell Medical, Inc.
- 20. Silver Creek Pharmaceuticals, Inc.
- 21. Stealth BioTherapeutics, Inc.
- 22. Teva Pharmaceutical Industries Ltd.
LIST OF FIGURES
- FIGURE 1. ACUTE KIDNEY INJURY TREATMENT MARKET RESEARCH PROCESS
- FIGURE 2. ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 5. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 7. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 8. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2023 VS 2030 (%)
- FIGURE 9. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 10. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 11. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 12. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 13. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 14. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 15. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 16. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 17. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 20. ACUTE KIDNEY INJURY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 21. ACUTE KIDNEY INJURY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. ACUTE KIDNEY INJURY TREATMENT MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 6. ACUTE KIDNEY INJURY TREATMENT MARKET DYNAMICS
- TABLE 7. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 8. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT), BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INTERMITTENT HEMODIALYSIS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 11. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY SUSTAINED LOW-EFFICIENCY DIALYSIS (SLED), BY REGION, 2018-2030 (USD MILLION)
- TABLE 12. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 13. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 14. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 15. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIURETICS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 16. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY IMMUNOSUPPRESSIVE AGENTS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 17. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 18. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 19. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INTRINSIC-RENAL ACUTE KIDNEY INJURY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 20. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY POST-RENAL ACUTE KIDNEY INJURY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 21. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRE-RENAL ACUTE KIDNEY INJURY, BY REGION, 2018-2030 (USD MILLION)
- TABLE 22. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 23. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 24. GLOBAL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 25. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 26. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 27. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 28. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 29. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 30. AMERICAS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 31. ARGENTINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 32. ARGENTINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 33. ARGENTINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 34. ARGENTINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 35. ARGENTINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 36. BRAZIL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 37. BRAZIL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 38. BRAZIL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 39. BRAZIL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 40. BRAZIL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 41. CANADA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 42. CANADA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 43. CANADA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 44. CANADA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 45. CANADA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 46. MEXICO ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 47. MEXICO ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 48. MEXICO ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 49. MEXICO ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 50. MEXICO ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 51. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 52. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 53. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 54. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 55. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 56. UNITED STATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 57. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 58. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 59. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 60. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 61. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 62. ASIA-PACIFIC ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 63. AUSTRALIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 64. AUSTRALIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 65. AUSTRALIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 66. AUSTRALIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 67. AUSTRALIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 68. CHINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 69. CHINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 70. CHINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 71. CHINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 72. CHINA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 73. INDIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 74. INDIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 75. INDIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 76. INDIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 77. INDIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 78. INDONESIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 79. INDONESIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 80. INDONESIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 81. INDONESIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 82. INDONESIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 83. JAPAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 84. JAPAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 85. JAPAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 86. JAPAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 87. JAPAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 88. MALAYSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 89. MALAYSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 90. MALAYSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 91. MALAYSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 92. MALAYSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 93. PHILIPPINES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 94. PHILIPPINES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 95. PHILIPPINES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 96. PHILIPPINES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 97. PHILIPPINES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 98. SINGAPORE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 99. SINGAPORE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 100. SINGAPORE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 101. SINGAPORE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 102. SINGAPORE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 103. SOUTH KOREA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 104. SOUTH KOREA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 105. SOUTH KOREA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 106. SOUTH KOREA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 107. SOUTH KOREA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 108. TAIWAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 109. TAIWAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 110. TAIWAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 111. TAIWAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 112. TAIWAN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 113. THAILAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 114. THAILAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 115. THAILAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 116. THAILAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 117. THAILAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 118. VIETNAM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 119. VIETNAM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 120. VIETNAM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 121. VIETNAM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 122. VIETNAM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 123. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 124. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 125. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 126. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 127. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 128. EUROPE, MIDDLE EAST & AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 129. DENMARK ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 130. DENMARK ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 131. DENMARK ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 132. DENMARK ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 133. DENMARK ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 134. EGYPT ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 135. EGYPT ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 136. EGYPT ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 137. EGYPT ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 138. EGYPT ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 139. FINLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 140. FINLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 141. FINLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 142. FINLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 143. FINLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 144. FRANCE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 145. FRANCE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 146. FRANCE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 147. FRANCE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 148. FRANCE ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 149. GERMANY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 150. GERMANY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 151. GERMANY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 152. GERMANY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 153. GERMANY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 154. ISRAEL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 155. ISRAEL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 156. ISRAEL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 157. ISRAEL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 158. ISRAEL ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 159. ITALY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 160. ITALY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 161. ITALY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 162. ITALY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 163. ITALY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 164. NETHERLANDS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 165. NETHERLANDS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 166. NETHERLANDS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 167. NETHERLANDS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 168. NETHERLANDS ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 169. NIGERIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 170. NIGERIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 171. NIGERIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 172. NIGERIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 173. NIGERIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 174. NORWAY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 175. NORWAY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 176. NORWAY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 177. NORWAY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 178. NORWAY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 179. POLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 180. POLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 181. POLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 182. POLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 183. POLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 184. QATAR ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 185. QATAR ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 186. QATAR ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 187. QATAR ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 188. QATAR ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 189. RUSSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 190. RUSSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 191. RUSSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 192. RUSSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 193. RUSSIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 194. SAUDI ARABIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 195. SAUDI ARABIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 196. SAUDI ARABIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 197. SAUDI ARABIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 198. SAUDI ARABIA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 199. SOUTH AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 200. SOUTH AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 201. SOUTH AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 202. SOUTH AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 203. SOUTH AFRICA ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 204. SPAIN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 205. SPAIN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 206. SPAIN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 207. SPAIN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 208. SPAIN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 209. SWEDEN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 210. SWEDEN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 211. SWEDEN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 212. SWEDEN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 213. SWEDEN ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 214. SWITZERLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 215. SWITZERLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 216. SWITZERLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 217. SWITZERLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 218. SWITZERLAND ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 219. TURKEY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 220. TURKEY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 221. TURKEY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 222. TURKEY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 223. TURKEY ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 224. UNITED ARAB EMIRATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 225. UNITED ARAB EMIRATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 226. UNITED ARAB EMIRATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 227. UNITED ARAB EMIRATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 228. UNITED ARAB EMIRATES ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 229. UNITED KINGDOM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
- TABLE 230. UNITED KINGDOM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DIALYSIS, 2018-2030 (USD MILLION)
- TABLE 231. UNITED KINGDOM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
- TABLE 232. UNITED KINGDOM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2018-2030 (USD MILLION)
- TABLE 233. UNITED KINGDOM ACUTE KIDNEY INJURY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 234. ACUTE KIDNEY INJURY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 235. ACUTE KIDNEY INJURY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
